Status:
UNKNOWN
Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world Study
Lead Sponsor:
Southern Medical University, China
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
To observe the effects of different treatments on the oncological outcome and complications of early cervical cancer (2018 FIGO stage IA1 with lymphovascular space invasion and IA2-IIA2 cervical cance...
Detailed Description
Objectives: To observe the effects of different treatments on the oncological outcome and complications of early cervical cancer (2018 FIGO stage IA1 with lymphovascular space invasion and IA2-IIA2 ce...
Eligibility Criteria
Inclusion
- Histologically confirmed primary adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, or other histological types carcinoma of the uterine cervix.
- Patients with Histologically confirmed stage IA1 (with lymph vascular invasion), FIGO 2018 stage IA2 to IIA2.
- Underwent radical hysterectomy or radiochemotherapy.
- ECOG Performance Status of 0 or 1.
Exclusion
- Life expectancy is less than 6 months
- No prior malignancy
- ECOG Performance Status of 2 to 5.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT04272190
Start Date
June 1 2020
End Date
January 1 2026
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China, 510515